Rising incidences of adverse drug reactions and resistance to the treatments in patients, coupled with high investment in the study of pharmacogenomics, is driving the market growth.
The Global Pharmacogenomics (PGx) Market size is forecasted to reach USD 11.01 billion from USD 5.66 billion in 2019, delivering a CAGR of 8.7% through 2027. The market growth is driven by...
Global Pharmacogenomics Market – Overview
The pharmacogenomics market value is growing at an incremental pace of development on the global stage due to the large number of advantages associated to personalized therapy. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, recently forecasted in its report on the Pharmacogenomics...
Pharmacogenomics or Pharmacogenetics, the study of genes and their impact on the way human body responses to the medication. The study combines pharmacology, the science of medicines and genomics, the study of genes and their functions to develop effective, safe medications and doses, personalized for a typical genetic makeup (person’s genetic structure). The main objective of this...
The global pharmacogenomics services market is expected to witness high growth, attributing to the global increase in the prevalence of infectious diseases and various types of cancers, increase in adoption of personalized medicine shifting the paradigm from reaction to prevention, rise in the rate of adverse drug reactions, and surge in the usage of pharmacogenomics for drug discovery and...